IrelandNew diagnostic tests for endometriosis have been approved for use in the UK's National Health Service (NHS), offering quicker diagnoses for women suspected of having the condition. The National Institute for Health and Care Excellence (NICE) has endorsed two tests—EndoSure and Endotest—as potential game-changers. EndoSure uses sensors on the abdomen to measure electrical signals in the gut, while Endotest analyzes saliva samples for specific biomarkers. Both tests aim to reduce the average nine-year wait for a diagnosis, which is currently common for endometriosis. A third test, DotEndo, was recommended for further research. The approval comes after surveys showing many women face lengthy journeys to diagnosis, often involving multiple visits to GPs and emergency departments. The new methods are intended to complement existing diagnostic tools like ultrasounds and MRIs, rather than replace them.
Bias read (Center): The article presents factual information about medical advancements without overt ideological framing. It discusses health policy and medical innovation objectively, focusing on improving patient outcomes. There is no indication of partisan bias or loaded language, making the framing neutral.
